Literature DB >> 19116880

Probiotics regulate the expression of COX-2 in intestinal epithelial cells.

Jan-Michel Otte1, Rudja Mahjurian-Namari, Stephan Brand, Ilka Werner, Wolfgang E Schmidt, Frank Schmitz.   

Abstract

Cyclooxygenase-2 (COX) 2 promotes intestinal wound healing but elicits also proinflammatory effects and has been implicated in colorectal carcinogenesis. Thus, a balanced expression of COX-2 is essential for intestinal homeostasis. This study was designed to evaluate the regulation of COX-2 by probiotic organisms and to characterize ligands and receptors involved. Colo320 and SW480 intestinal epithelial cells (IEC) were stimulated with gastrin or TNF-alpha and pre- or coincubated with commensales, bacterial supernatants, or distinct toll-like receptor (TLR) ligands. COX-2 promoter activity was determined by luciferase assays, protein expression by Western blotting, and secretion of prostaglandin E(2) (PGE(2)) by ELISA. Commensales differentially regulated COX-2 expression in IEC. E. coli Nissle 1917, the probiotic mixture VSL#3, and media conditioned by these organisms ameliorated induced COX-2 expression and PGE(2) secretion. Heat inactivation and DNase treatment significantly decreased these regulatory capacities. Lactobacillus acidophilus, however, significantly increased COX-2 expression and PGE(2) secretion. TLR agonists differentially ameliorated basal or induced COX-2 expression. Distinct probiotics specifically and significantly decrease induced COX-2 expression in IEC, most likely mediated by released factors and in part by bacterial DNA. A significant involvement of TLRs in these regulatory processes remains to be established.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19116880     DOI: 10.1080/01635580802372625

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  25 in total

Review 1.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

2.  S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity.

Authors:  Valentina Taverniti; Milda Stuknyte; Mario Minuzzo; Stefania Arioli; Ivano De Noni; Christian Scabiosi; Zuzet Martinez Cordova; Ilkka Junttila; Sanna Hämäläinen; Hannu Turpeinen; Diego Mora; Matti Karp; Marko Pesu; Simone Guglielmetti
Journal:  Appl Environ Microbiol       Date:  2012-12-07       Impact factor: 4.792

Review 3.  Probiotics: properties, examples, and specific applications.

Authors:  Judith Behnsen; Elisa Deriu; Martina Sassone-Corsi; Manuela Raffatellu
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

4.  Lactobacillus rhamnosus GG increases cyclooxygenase-2 expression and prostaglandin E2 secretion in colonic myofibroblasts via a MyD88-dependent mechanism during homeostasis.

Authors:  Gabriela Uribe; Romain Villéger; Philippe Bressollier; Rachel N Dillard; Daniel L Worthley; Timothy C Wang; Don W Powell; Maria C Urdaci; Irina V Pinchuk
Journal:  Cell Microbiol       Date:  2018-07-26       Impact factor: 3.715

5.  In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product.

Authors:  Valentina Taverniti; Mario Minuzzo; Stefania Arioli; Ilkka Junttila; Sanna Hämäläinen; Hannu Turpeinen; Diego Mora; Matti Karp; Marko Pesu; Simone Guglielmetti
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

6.  Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis.

Authors:  Ludmila Khailova; Sarah K Mount Patrick; Kelly M Arganbright; Melissa D Halpern; Toshi Kinouchi; Bohuslav Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-12       Impact factor: 4.052

7.  Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage.

Authors:  Luca D Prisciandaro; Mark S Geier; Ann E Chua; Ross N Butler; Adrian G Cummins; Guy R Sander; Gordon S Howarth
Journal:  Support Care Cancer       Date:  2012-04-20       Impact factor: 3.603

8.  Escherichia coli Nissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage.

Authors:  Hanru Wang; Susan E P Bastian; Ker Y Cheah; Andrew Lawrence; Gordon S Howarth
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

9.  Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions.

Authors:  Francesca Turroni; Fausta Serafini; Elena Foroni; Sabrina Duranti; Mary O'Connell Motherway; Valentina Taverniti; Marta Mangifesta; Christian Milani; Alice Viappiani; Tommaso Roversi; Borja Sánchez; Andrea Santoni; Laura Gioiosa; Alberto Ferrarini; Massimo Delledonne; Abelardo Margolles; Laura Piazza; Paola Palanza; Angelo Bolchi; Simone Guglielmetti; Douwe van Sinderen; Marco Ventura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

10.  Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease.

Authors:  David Briskey; Mandy Heritage; Lesley-Anne Jaskowski; Jonathan Peake; Glenda Gobe; V Nathan Subramaniam; Darrell Crawford; Catherine Campbell; Luis Vitetta
Journal:  Therap Adv Gastroenterol       Date:  2016-05-01       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.